We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
+18.31%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$2.72B
AUM Growth
+$244M
Cap. Flow
+$33.9M
Cap. Flow %
1.25%
Top 10 Hldgs %
66.52%
Holding
104
New
19
Increased
17
Reduced
17
Closed
18

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$53.9M
2
WW
WW International
WW
+$15.8M
3
MA icon
Mastercard
MA
+$13.3M
4
DAL icon
Delta Air Lines
DAL
+$11.5M
5
FSL
FREESCALE SEMICONDUCTOR LTD
FSL
+$7.47M

Top Sells

Rank Stock Value
1
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
+$21.5M
2
AMZN icon
Amazon
AMZN
+$16.2M
3
C icon
Citigroup
C
+$15.1M
4
TEX icon
Terex
TEX
+$8.22M
5
ACOR
Acorda Therapeutics
ACOR
+$5.47M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33%
2 Healthcare 20.75%
3 Financials 0.8%
4 Technology 0.57%
5 Industrials 0.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPHS
76
DELISTED
Sophiris Bio, Inc.
SPHS
$2.93M 0.11%
1,000,000
– –
PARN
77
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$2.88M 0.11%
+500,000
New +$3.01M
IRWD icon
78
Ironwood Pharmaceuticals
IRWD
$586M
$2.81M 0.1%
258,954
– –
STML
79
DELISTED
Stemline Therapeutics, Inc.
STML
$2.12M 0.08%
170,000
– –
OUT icon
80
Outfront Media
OUT
$5.75B
$1.95M 0.07%
+87,017
New +$2.13M
CSLT
81
CALL
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$1.29M 0.05%
100,000
– –
AGEN
82
Agenus
AGEN
$276M
$1.28M 0.05%
20,896
– –
SFXE
83
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
$1.25M 0.05%
250,000
– –
CCXI
84
DELISTED
ChemoCentryx, Inc.
CCXI
$1.24M 0.05%
275,000
– –
AMRN
85
CALL
Amarin Corp
AMRN
$297M
$545K 0.02%
25,000
– –
CCXI
86
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
$450K 0.02%
+100,000
New +$529K
AMGN icon
87
CALL
Amgen
AMGN
$209B
– –
-400,000
Closed -$47.3M
AMZN icon
88
Amazon
AMZN
$2.44T
– –
-1,000,000
Closed -$16.2M
ARMK icon
89
Aramark
ARMK
$15B
– –
-277,000
Closed -$5.18M
BAC icon
90
Bank of America
BAC
$429B
– –
-100,000
Closed -$1.59M
BRFS
91
CALL
DELISTED
BRF SA
BRFS
– –
-500,000
Closed -$12.2M
C icon
92
Citigroup
C
$213B
– –
-300,000
Closed -$15.1M
CL icon
93
CALL
Colgate-Palmolive
CL
$74.8B
– –
-250,000
Closed -$17M
GILD icon
94
CALL
Gilead Sciences
GILD
$165B
– –
-250,000
Closed -$20.7M
LLY icon
95
CALL
Eli Lilly
LLY
$1.08T
– –
-200,000
Closed -$12.4M
NKTR icon
96
CALL
Nektar Therapeutics
NKTR
$2.39B
– –
-53,333
Closed -$10.3M
RDN icon
97
Radian Group
RDN
$5.28B
– –
-200,000
Closed -$2.96M
TEX icon
98
Terex
TEX
$7.37B
– –
-200,000
Closed -$8.22M
ZTS icon
99
CALL
Zoetis
ZTS
$32.7B
– –
-300,000
Closed -$9.68M
ONIT
100
Onity Group
ONIT
$342M
– –
-6,667
Closed -$3.01M
1 2 3
4
5

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q3 2014 Portfolio in Review

As of Q3 2014, Artal Group held 104 positions worth $2.72B, up 9.8% from $2.47B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Artal Group's Q3 2014 filing shows 19 new, 17 increased, 17 reduced and 18 closed positions. Its largest new stake was Alibaba: 600,000 shares worth $53.3M. The largest sale was AUXILIUM PHARAMCEUTICALS INC, an estimated $21.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Artal Group's largest Q3 2014 buy was Alibaba: 600,000 shares worth $53.3M.
  • Artal Group added most to WW International in Q3 2014, an estimated $15.8M increase.
  • Artal Group's biggest Q3 2014 reduction was AUXILIUM PHARAMCEUTICALS INC, cutting an estimated $21.5M.
  • Artal Group fully exited Amazon in Q3 2014, selling an estimated $16.2M.
  • Artal Group's ten largest holdings make up 67% of its $2.72B portfolio in Q3 2014.
  • Artal Group opened 19 new positions and closed 18 in Q3 2014.
  • Artal Group's portfolio value rose 9.8% quarter-over-quarter to $2.72B.

Based on Artal Group's 13F filing for Q3 2014, filed 13 Nov 2014.